Vimian Group AB (publ) (0V0.F)
- Previous Close
2.5600 - Open
2.4250 - Bid 2.4650 x --
- Ask 2.5600 x --
- Day's Range
2.4250 - 2.4250 - 52 Week Range
1.7610 - 3.3000 - Volume
277 - Avg. Volume
164 - Market Cap (intraday)
1.315B - Beta (5Y Monthly) 1.52
- PE Ratio (TTM)
121.25 - EPS (TTM)
0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
vimian.com1,100
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0V0.F
Performance Overview: 0V0.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0V0.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0V0.F
Valuation Measures
Market Cap
1.31B
Enterprise Value
1.59B
Trailing P/E
125.22
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.42
Price/Book (mrq)
2.41
Enterprise Value/Revenue
4.80
Enterprise Value/EBITDA
22.49
Financial Highlights
Profitability and Income Statement
Profit Margin
2.97%
Return on Assets (ttm)
2.85%
Return on Equity (ttm)
2.08%
Revenue (ttm)
331.73M
Net Income Avi to Common (ttm)
9.84M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
37.5M
Total Debt/Equity (mrq)
59.58%
Levered Free Cash Flow (ttm)
-14.81M
Company Insights: 0V0.F
0V0.F does not have Company Insights